Kamada Ltd. (TLV:KMDA)
Israel
· Delayed Price · Currency is ILS · Price in ILA 2,709.00
-94.00 (-3.35%)
At close: Mar 9, 2026
Kamada Employees
Kamada had 420 employees as of December 31, 2024. The number of employees increased by 42 or 11.11% compared to the previous year.
Employees
420
Change (1Y)
42
Growth (1Y)
11.11%
Revenue / Employee
1.38M ILS
Profits / Employee
161.17K ILS
Market Cap
1.62B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Teva Pharmaceutical Industries | 32,842 |
| Danel (Adir Yeoshua) | 4,290 |
| BrainsWay | 120 |
| SofWave Medical | 126 |
| Bait Bakfar | 227 |
| Ilex Medical | 178 |
| Novolog (Pharm-Up 1966) | 936 |
| Bonus BioGroup | 37 |
Kamada News
- 3 days ago - Ahead of Kamada (KMDA) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics - Nasdaq
- 2 months ago - Kamada (KMDA) Projects Strong Revenue and EBITDA Growth by 2026 - GuruFocus
- 2 months ago - Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender - GlobeNewsWire
- 3 months ago - Kamada Ltd Corporate Update Call Transcript - GuruFocus
- 3 months ago - Kamada Shuts Down Phase 3 Study For Genetic Condition, Reiterates Outlook - Benzinga
- 3 months ago - Kamada Shuts Down Phase 3 Study For Genetic Condition, Reiterates Outlook - Benzinga
- 3 months ago - Kamada Ltd. (KMDA) Discusses Discontinuation of Phase 3 Inhaled AAT Clinical Trial and Financial Outlook Transcript - Seeking Alpha
- 3 months ago - Kamada (KMDA) Halts Phase 3 Trial of Inhaled AAT for Alpha-1 Antitrypsin Deficiency - GuruFocus